Thursday, November 6

Browsing: ImmuneMediated

Economy & Business

2 Mins Read

Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Goal and EQ504 Program in Immune-Mediated Ailments Transcript

By Admin06/11/20252 Mins Read

ObservePlay Earnings NamePlay Earnings Name Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Goal and EQ504 Program in…